Copyright
©The Author(s) 2021.
World J Clin Cases. Apr 26, 2021; 9(12): 2721-2730
Published online Apr 26, 2021. doi: 10.12998/wjcc.v9.i12.2721
Published online Apr 26, 2021. doi: 10.12998/wjcc.v9.i12.2721
Table 1 Demographic and clinical data of cases and controls
Subjects | Gender (n) | Mean age in yr | Pathologic features (n) | Stage (n) | Size in cm |
Lung cancer patients (n = 106) | Male (47), Female (59) | 59 | AAH (1) | Ia (84) | 2.03 ± 1.06 |
AIS (10) | Ib (10) | ||||
MIA (11) | IIa (2) | ||||
IAC (83) | IIb (7) | ||||
III (3) | |||||
Benign controls (n = 11) | Male (4), Female (7) | 49 | IPT (6)1 | NA | |
Tuberculoma (2) | |||||
Hamartoma (1) | |||||
Fibroma (1) | |||||
Pleural tumor (1) | |||||
Healthy controls (n = 17) | Male (10), Female (7) | 31 | NA | NA | NA |
- Citation: Jiang SS, Mao CG, Feng YG, Jiang B, Tao SL, Tan QY, Deng B. Circulating tumor cells with epithelial-mesenchymal transition markers as potential biomarkers for the diagnosis of lung cancer. World J Clin Cases 2021; 9(12): 2721-2730
- URL: https://www.wjgnet.com/2307-8960/full/v9/i12/2721.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i12.2721